Staging of cytoskeletal and β-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease

American Journal of Pathology

Volumn 157, Issue 2, 2000, Pages 623-636

  Mukaetova Ladinska, Elizabeta B ^a   Garcia Siera, Francisco ^b   Hurt, Jenny ^a   Gertz, Herman J ^c   Xuereb, John H ^a   Hills, Richard ^a   Brayne, Carol ^d   Huppert, Felicia A ^a   Paykel, Eugene S ^a   McGee, Magnus ^d   Jakes, Ross ^e   Honer, William G ^f   Harrington, Charles R ^g   Wischik, Claude M ^g  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; SYNAPTOPHYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CYTOSKELETON; DEAFFERENTATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; MALE; NERVE FIBER TRANSPORT; OLFACTORY CORTEX; PRIORITY JOURNAL; PROTEIN AGGREGATION; STAGING;

EID: 0033899864     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64573-7     Document Type: Article

References (70)

1. Incidence of dementia in a population older than 75 years in the United Kingdom
2. Incidence of dementia and cognitive decline in over-75s in Cambridge: Overview of cohort study
3. Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge Project for Later Life
4. Measurement of distinct immunochemical presentations of tau protein in Alzheimer's disease
5. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease
6. Regional distribution of paired helical filaments and normal tau proteins in aging and in Alzheimer's disease with and without occipital lobe involvement
7. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease
8. Distribution of tau protein in Down's syndrome: Quantitative differences from Alzheimer's disease
9. Alterations in tau protein metabolism during normal aging
10. Authors response to commentaries. What causes neurofibrillary tangle formation in Alzheimer's disease?
11. Examination of phosphorylated tau protein as a PHF precursor at early stage Alzheimer's disease
12. Neuropathological staging of Alzheimer-related changes
13. CAMDEX: A standardised instrument for the diagnosis of mental disorder in the elderly with special references to the early detection of dementia
14. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
15. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
16. The response of elderly community residents to request for brain donation: An interim report
17. The relationship between clinical dementia and neuropathological staging (Braak) in a very elderly community sample
18. Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease
19. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
20. A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain
21. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia
22. Monoclonal antibodies to study the brain in schizophrenia
23. Identification of two distinct synucleins from human brain
24. Differences in the cellular distributions of two microtubule associated proteins, MAP1 and MAP2, in rat brain
25. Correlations of synaptic and pathological markers with cognition of the elderly
26. Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease
27. Amyloid β-protein and the genetics of Alzheimer's disease
28. Cellular action of β-amyloid precursor protein and its soluble and fibrillogenic derivatives
29. A68: A major subunit of paired helical filaments and derivatized forms of normal tau
30. Tau proteins and neurofibrillary degeneration
31. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms
32. The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs
33. Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau
34. 262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding
35. Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines
36. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament
37. The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease
38. Diffuse plaques do not accentuate synapse loss in Alzheimer disease
39. Quantitation of amyloid β-protein (Aβ) in the cortex during aging and Alzheimer's disease
40. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease
41. Quantitative synaptic alterations in the human neocortex during normal aging
42. Synapse loss in the temporal lobe in Alzheimer's disease
43. Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with dementia of Alzheimer type and non-demented controls
44. Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration
45. Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration
46. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease
47. Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study
48. Synaptic and neuritic alterations during the progression of Alzheimer's disease
49. Microtubule protein phosphorylation in neuroblastoma cells and neurite growth
50. Cloning of human GAP-43: Growth association and ischemic resurgence
51. Lesion-induced sprouting of commissural/association axons and induction of GAP-43 mRNA in hillar and CA3 pyramidal neurons in the hippocampus are diminished in aged rats
52. Nerve growth factor treatment prevents dendritic atrophy and promotes recovery of function after cortical injury
53. Synaptic loss in cognitively impaired aged rats is ameliorated by chronic human nerve growth factor infusion
54. NGF-mediated synaptic sprouting in the cerebral cortex of lesioned primate brain
55. Nerve growth factor in Alzheimer's disease: Increased levels throughout the brain coupled with declines in nucleus basalis
56. Regional specificity in NGF, BDNF and NT-3 levels in Alzheimer's disease
57. Thrombin causes cell spreading and redistribution of β-amyloid immunoreactivity in cultured hippocampal neurons
58. Patterns of aberrant sprouting in Alzheimer's disease
59. Distribution of neuronal growth-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly
60. Altered expression of transforming growth factor-β in Alzheimer's disease
61. Fibroblast growth factor (FGF)-9 immunoreactivity in senile plaques
62. Microtubule-associated protein 2: Monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles
63. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease
64. Specific monoclonal antibodies against normal microtubule-associated protein -2 (MAP2) epitopes present in Alzheimer pathological structures do not recognize paired helical filaments
65. An immunocytochemical and biochemical study of the microtubule-associated protein MAP-2 during postlesion dendritic remodelling in the central nervous system of adult rats
66. Actin depolymerisation induces process formation on MAP2-transfected non-neuronal cells
67. Changes in the microtubule proteins in the developing and transected spinal cords of the bullfrog tadpole: Induction of microtubule-associated protein 2c and enhanced levels of tau and tubulin in regenerating central axons
68. Enhanced expression of microtubule-associated protein 2 in large neurons of cortical dysplasia
69. Alzheimer's disease: Transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon's horn
70. Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease